WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced changes to the prescribing information in the United States for the ...
Findings from a large-base (133) sample of Asian patients under the cholesterol-lowering therapy simvastatin supervised by doctors treating patients with coronary heart disease (CHD) turned up new ...
DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Simvastatin Market, 2019-2023" report has been added to ResearchAndMarkets.com's offering. The blood lipid levels of Chinese people are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback